文献速递间质性肺疾病

纤维化间质性肺病患者的职场生产力损失及其费用

Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.
PubMed 文献 · Chest · 2019-04-30

基于加拿大六中心 CARE-PF 注册队列,纳入特发性肺纤维化、慢性过敏性肺炎、特发性非特异性间质性肺炎或不可分类 ILD 患者,用 WPAI 问卷评估健康相关生产力损失。650 例中 148 例(23%)在职,55% 报告生产力损失,平均每周损失 7.8±0.9 小时。呼吸困难与咳嗽为独立预测因素,每名在职患者年生产力损失估计为 11,610 加元。

要点

  • 在职纤维化 ILD 患者中 55% 存在生产力损失,平均每周 7.8 小时。
  • 损失以 presenteeism 为主(每周 5.5 小时),缺勤为每周 2.3 小时。
  • 呼吸困难与咳嗽是职场生产力损失的独立预测因素。

核心结论

  • 职场生产力损失在纤维化 ILD 中常见,与症状严重程度强相关并带来显著费用。

研究设计与样本

  • 来自加拿大六中心 CARE-PF 注册队列,纳入 IPF、慢性过敏性肺炎、特发性 NSIP 或不可分类 ILD 患者。
  • 使用 WPAI 问卷判定健康相关生产力损失,并以多因素回归识别低职场生产力的独立预测因素。
  • 将患者数据与加拿大人口普查数据比较,用平均每周生产力损失小时数与个人时薪估算费用。

主要发现

  • 650 例合格患者中 148 例(23%)在职。
  • 在职患者中 55% 报告生产力损失,平均每周损失 7.8±0.9 小时(缺勤 2.3±0.6 小时,presenteeism 5.5±0.6 小时)。
  • 25 至 54 岁 ILD 患者就业率较年龄性别匹配的加拿大一般人群低 23%(60% 对 83%;P < .001)。
  • ≥ 55 岁 ILD 患者就业率较年龄性别匹配人群低 18%(20% 对 38%;P < .001)。
  • 呼吸困难与咳嗽是职场生产力损失的独立预测因素。

关键数值与推荐

  • 在职患者平均每周生产力损失 7.8±0.9 小时,其中缺勤 2.3±0.6 小时、presenteeism 5.5±0.6 小时。
  • 25 至 54 岁就业率 60% 对 83%(P < .001);≥ 55 岁就业率 20% 对 38%(P < .001)。
  • 每名在职 ILD 患者年生产力损失估计费用为 11,610 加元。

临床怎么用

  • 接诊工作年龄纤维化 ILD 患者时应询问就业状况与工作受限情况。
  • 可将呼吸困难与咳嗽控制作为减少职场生产力损失的关注靶点。
  • 生产力损失费用数据可用于职业健康与疾病负担沟通。

局限性

  • 仅 23% 合格患者在职,样本以在职者为主,可能低估整体疾病负担。
  • 费用估算基于平均生产力损失小时数与个人时薪,未涵盖非医疗间接费用。
  • 为注册队列观察性分析,无法确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibrotic interstitial lung diseases (ILDs) are highly morbid chronic disorders that frequently occur in working age individuals. The goal of this study was to determine workplace productivity loss, its determinants, and its estimated costs in patients with fibrotic ILD. METHODS: Patients with idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, idiopathic nonspecific interstitial pneumonia, or unclassifiable ILD were identified from the six-center Canadian Registry for Pulmonary Fibrosis (CARE-PF). The Work Productivity and Activity Impairment questionnaire was used to determine health-related productivity loss. Independent predictors of low workplace productivity were identified by using multivariate regression. Patient data were compared with Canadian population census data. The average productivity loss (hours per week) and the individual's hourly wage were used to estimate the costs of productivity loss. RESULTS: Of 650 eligible patients, 148 (23%) were employed. Productivity loss was reported by 55% of employed patients with an average productivity loss of 7.8 ± 0.9 h per week (2.3 ± 0.6 h per week related to absenteeism and 5.5 ± 0.6 h per week related to presenteeism). Employment among patients with ILD aged 25 to 54 years was 23% lower than the age- and sex-matched general Canadian population (60% vs 83%; P < .001). Employment among patients with ILD aged ≥ 55 years was 18% lower than in the age- and sex-matched population (20% vs 38%; P < .001). Dyspnea and cough were independent predictors of workplace productivity loss. Estimated annual costs of productivity loss were 11,610 Canadian dollars per employee with ILD. CONCLUSIONS: Workplace productivity loss is common in fibrotic ILD, strongly correlated with symptom severity, and associated with significant cost.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Algamdi M, Sadatsafavi M, Fisher JH, et al. Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. Chest. 2019. PMID: 31051170. doi:10.1016/j.chest.2019.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。